Market Place
Sourcing Support
Almirall Completes Efinaconazole Approval Procedure In Europe
15 Oct 2024 //
BUSINESSWIRE
Zydus Pharm Generic Fingolimod HCL Receives Tentative Approval in the U.S.
15 Jul 2022 //
FDA
Lupin receives USFDA approval for anti-fungal drug
03 Mar 2022 //
BUSINESS-STANDARD
Lupin Ltd`s Generic Efinaconazole Receives Approval in the U.S.
02 Mar 2022 //
FDA
Acrux Dds`s Generic Efinaconazole Receives Approval In US
23 Jun 2021 //
FDA
Aleor gets tentative USFDA approval for Efinaconazole Topical
08 Apr 2021 //
EXPRESSPHARMA.IN/DRUG-APPROVALS/ALEOR-DE
Zydus Cadila seeks govt nod to start Phase-III clinical trials of COVID-19
23 Dec 2020 //
ECONOMIC TIMES
Zydus Cadila seeks govt nod to start Phase-III clinical trials of COVID-19
23 Dec 2020 //
ECONOMICTIMES
Perrigo Pharma`s Generic Efinaconazole Receives Approval in US
22 Dec 2020 //
FDA
Global Efinaconazole Market Expected to Reach USD 875 Million by 2026
20 Mar 2020 //
GALUSAUSTRALIS
Teva Pharms` Generic Efinaconazole Receives Tentative Approval in US
18 Oct 2019 //
FDA
Perrigo Announces Patent Litigation Settlement for Generic Version of Jublia
14 Feb 2019 //
PR NEWSWIRE
Temad Co from Brasov looks to expand to Caucasus after sales up 7%
29 Jan 2019 //
ZF
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken vs. Amneal Pharma
02 Oct 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. KVK-Tech
02 Oct 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Mylan
02 Oct 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Acrux DDS Pty Ltd.
25 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Cipla Ltd.
25 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Macleods Pharma
24 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Apotex Corp.
24 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Perrigo Pharma
24 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) :Valeant Pharmaceuticals vs. Teva Pharma USA
22 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole): Valeant Pharma, Dow Pharma, Kaken v. Aleor Dermaceutical
22 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken Pharma v. Lupin
15 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken Pharma v. Alkem Labs
15 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Strides Pharma
15 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Aurobindo Pharma
15 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharmac v. Par Pharmaceutical
11 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken Pharma vs. Zydus Pharma
07 Sep 2018 //
PATENT LITIGATION
Argentum Wins Patent Invalidation Trial Against Patent on Valeant`s JUBLIA®
07 Jun 2018 //
PR NEWSWIRE
Valeant Pharmaceuticals Comments On Management Change
03 Mar 2016 //
PR NEWS WIRE
Drug Spending Slowed in 2015 After Discounts, CVS Health Says
24 Feb 2016 //
BLOOMBERG
Valeant, AstraZeneca played the Super Bowl ad game, but did they win?
08 Feb 2016 //
FIERCE PHARMA MARKETING
Valeant Announces New U.S. Fulfillment Agreements With Walgreens
16 Dec 2015 //
PR NEWS WIRE
Exclusive: U.S. drug benefit managers clamp down on specialty pharmacies
16 Nov 2015 //
REUTERS
Emmy co-host Mario Lopez spotlights Valeant`s Jublia on the red carpet
23 Sep 2015 //
FIERCE PHARMA MARKETING
